The ever-increasing number of potential therapeutic targets that are emerging from genomics and proteomics is driving the need to develop new synthetic technologies able to prepare small molecules as potential modulators. 1 In particular, flow processes, both on a microfluidic 2 and mesofluidic scale, 3 are receiving increased attention and offer a number of potential advantages over existing batch techniques. For example, reaction conditions (flow rate, stoichiometry, ...
[Ley, Steven V.; Schucht, Olivier; Thomas, Andrew W.; Murray, P. John Journal of the Chemical Society - Perkin Transactions 1, 1999 , # 10 p. 1251 - 1252]
[Ley, Steven V.; Schucht, Olivier; Thomas, Andrew W.; Murray, P. John Journal of the Chemical Society - Perkin Transactions 1, 1999 , # 10 p. 1251 - 1252]